AGIO
AGIOS PHARMACEUTICALS, INC.
+1.01 (+3.07%)33.96USD177K成交股數2.0B市值–本益比(近四季)20.6股價營收比+259.3%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 44.7M+259% | 20.7M+138% | 20.0M+123% | 12.9M+50% | 12.5M+52% | 8.7M+23% | 9.0M+21% | 8.6M+28% | 8.2M | 7.1M | 7.4M | 6.7M |
| 營業成本 | 3.0M | 1.3M | 1.9M | 1.7M | 1.7M | 1.1M | 783K | 1.5M | 627K | 586K | 633K | 1.1M |
| 毛利 | 41.7M+288% | 19.4M+154% | 18.1M+121% | 11.2M+57% | 10.8M+42% | 7.6M+17% | 8.2M+21% | 7.1M+27% | 7.6M | 6.5M | 6.8M | 5.6M |
| 毛利率 | 93.3% | 93.6% | 90.6% | 87.0% | 86.3% | 87.6% | 91.3% | 82.6% | 92.3% | 91.7% | 91.4% | 83.5% |
| 研發費用 | 101M | 81.1M | 88.1M | 86.8M | 91.9M | 72.7M | 72.5M | 77.4M | 68.6M | 77.5M | 81.8M | 68.9M |
| 銷售管理費用 | 51.5M | 48.3M | 51.6M | 41.3M | 45.9M | 41.5M | 38.5M | 35.5M | 31.0M | 35.3M | 25.8M | 30.4M |
| 營業利益 | −111M-13% | −110M+3% | −122M+18% | −117M+10% | −127M+38% | −107M+0% | −103M+2% | −106M+13% | −92.1M | −106M | −101M | −93.7M |
| 營業利益率 | -247.1% | -530.3% | -608.9% | -907.4% | -1,020.1% | -1,222.0% | -1,146.9% | -1,228.3% | -1,124.3% | -1,496.2% | -1,363.7% | -1,396.0% |
| 稅後淨利 | −101M-10% | −99.1M+11% | −108M-111% | −103M+8% | −112M+37% | −89.3M-7% | 948M-1138% | −96.1M+15% | −81.5M | −95.9M | −91.3M | −83.8M |
| 淨利率 | -225.1% | -477.7% | -542.2% | -803.1% | -899.4% | -1,023.3% | 10,574.7% | -1,115.7% | -995.8% | -1,349.5% | -1,234.3% | -1,248.6% |
| 稀釋 EPS | -1.69-12% | -1.69+9% | -1.86-111% | -1.78+5% | -1.93+33% | -1.55-9% | 16.22-1089% | -1.69+12% | -1.45 | -1.71 | -1.64 | -1.51 |
| 稀釋股數 | 59.5M | 58.8M | 58.0M | 58.1M | 57.9M | 57.5M | 58.4M | 56.8M | 56.4M | 55.7M | 55.8M | 55.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 99.6M | 114M | 89.1M | 92.7M | 80.9M | 79.0M | 254M | 84.5M | 119M | 88.2M | 64.3M | 84.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 35.8M | 35.1M | 32.9M | 32.0M | 30.8M | 29.6M | 26.4M | 23.9M | 23.1M | 19.1M | 17.3M | 15.7M |
| 總資產 | 1.1B | 1.2B | 1.3B | 1.4B | 1.5B | 1.6B | 1.8B | 773M | 850M | 937M | 1.0B | 1.1B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 82.4M | 75.9M | 104M | 101M | 102M | 89.0M | 165M | 113M | 106M | 126M | 120M | 121M |
| 股東權益 | 1.0B | 1.1B | 1.2B | 1.3B | 1.4B | 1.5B | 1.6B | 661M | 744M | 811M | 887M | 964M |
| 負債比 | 7.4% | 6.4% | 8.0% | 7.3% | 6.9% | 5.7% | 9.2% | 14.6% | 12.4% | 13.5% | 12.0% | 11.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −119M+7% | – | – | – | −111M | – | – | −99.9M | – | – | – |
| 資本支出 | – | 769K | – | – | – | 766K | – | – | 141K | – | – | – |
| 自由現金流 | – | −120M+7% | – | – | – | −112M | – | – | −100M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -576.9% | – | – | – | -1,286.4% | – | – | -1,221.2% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 54.0M
| 產品 | 54.0M | 100.0% | +48.0% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 54.0M | +48.0% | −413M | -764.4% | -7.12 | −377M |
| FY2024 | 36.5M | +36.1% | 674M | 1,846.7% | 11.64 | −392M |
| FY2023 | 26.8M | +88.4% | −352M | -1,312.3% | -6.33 | −297M |
| FY2022 | 14.2M | – | −232M | -1,629.2% | -4.23 | −314M |
| FY2021 | 0.00 | – | 1.6B | –% | 26.55 | −413M |
| FY2020 | 0.00 | -100.0% | −327M | –% | -4.74 | −305M |
| FY2019 | 118M | +24.9% | −411M | -349.0% | -6.86 | −383M |
| FY2018 | 94.4M | – | −346M | -366.6% | -6.03 | −311M |